Inside informationEnglish
AB Science receives regulatory approval from European countries to initiate third stage of Phase I/II study combining its molecule AB8939 with venetoclax for the treatment of AML
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- AB Science
- Filed
- 30/07/2025, 07:45
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 110402_20250730